Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years

Uterine artery embolization (UAE) for the treatment of symptomatic uterine fibroids and non-controllable adenomyosis symptoms is a relatively new procedure for organ-preserving therapy. These benign conditions can become symptomatic in about 30% of women between the ages of 35 and 50. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsikouras, Panagiotis, Oikonomou, Efthymios, Tsatsaris, George, Bothou, Anastasia, Kyriakou, Dimitrios, Nikolettos, Konstantinos, Nalmbanti, Theopi, Peitsidis, Panagiotis, Trypsanis, Grigorios, Iatrakis, George, Nikolettos, Nikolaos, Souftas, Vasileios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532514/
https://www.ncbi.nlm.nih.gov/pubmed/37763151
http://dx.doi.org/10.3390/jpm13091385
_version_ 1785111978531880960
author Tsikouras, Panagiotis
Oikonomou, Efthymios
Tsatsaris, George
Bothou, Anastasia
Kyriakou, Dimitrios
Nikolettos, Konstantinos
Nalmbanti, Theopi
Peitsidis, Panagiotis
Trypsanis, Grigorios
Iatrakis, George
Nikolettos, Nikolaos
Souftas, Vasileios
author_facet Tsikouras, Panagiotis
Oikonomou, Efthymios
Tsatsaris, George
Bothou, Anastasia
Kyriakou, Dimitrios
Nikolettos, Konstantinos
Nalmbanti, Theopi
Peitsidis, Panagiotis
Trypsanis, Grigorios
Iatrakis, George
Nikolettos, Nikolaos
Souftas, Vasileios
author_sort Tsikouras, Panagiotis
collection PubMed
description Uterine artery embolization (UAE) for the treatment of symptomatic uterine fibroids and non-controllable adenomyosis symptoms is a relatively new procedure for organ-preserving therapy. These benign conditions can become symptomatic in about 30% of women between the ages of 35 and 50. The purpose of the UAE either for fibroids or adenomyosis is the elimination of blood loss, the reduction in pain, and bulky or rectal pressure symptoms. The purpose of this study is to present our experience in UAE with the use of hydrogel-coated tris acryl microspheres for the treatment of symptomatic uterine fibroids and adenomyosis.
format Online
Article
Text
id pubmed-10532514
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105325142023-09-28 Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years Tsikouras, Panagiotis Oikonomou, Efthymios Tsatsaris, George Bothou, Anastasia Kyriakou, Dimitrios Nikolettos, Konstantinos Nalmbanti, Theopi Peitsidis, Panagiotis Trypsanis, Grigorios Iatrakis, George Nikolettos, Nikolaos Souftas, Vasileios J Pers Med Article Uterine artery embolization (UAE) for the treatment of symptomatic uterine fibroids and non-controllable adenomyosis symptoms is a relatively new procedure for organ-preserving therapy. These benign conditions can become symptomatic in about 30% of women between the ages of 35 and 50. The purpose of the UAE either for fibroids or adenomyosis is the elimination of blood loss, the reduction in pain, and bulky or rectal pressure symptoms. The purpose of this study is to present our experience in UAE with the use of hydrogel-coated tris acryl microspheres for the treatment of symptomatic uterine fibroids and adenomyosis. MDPI 2023-09-15 /pmc/articles/PMC10532514/ /pubmed/37763151 http://dx.doi.org/10.3390/jpm13091385 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tsikouras, Panagiotis
Oikonomou, Efthymios
Tsatsaris, George
Bothou, Anastasia
Kyriakou, Dimitrios
Nikolettos, Konstantinos
Nalmbanti, Theopi
Peitsidis, Panagiotis
Trypsanis, Grigorios
Iatrakis, George
Nikolettos, Nikolaos
Souftas, Vasileios
Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title_full Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title_fullStr Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title_full_unstemmed Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title_short Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
title_sort our experience with hydrogel-coated trisacryl microspheres in uterine artery embolization for the treatment of symptomatic uterine fibroids and adenomyosis: a follow-up of 11 years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532514/
https://www.ncbi.nlm.nih.gov/pubmed/37763151
http://dx.doi.org/10.3390/jpm13091385
work_keys_str_mv AT tsikouraspanagiotis ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT oikonomouefthymios ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT tsatsarisgeorge ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT bothouanastasia ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT kyriakoudimitrios ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT nikolettoskonstantinos ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT nalmbantitheopi ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT peitsidispanagiotis ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT trypsanisgrigorios ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT iatrakisgeorge ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT nikolettosnikolaos ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years
AT souftasvasileios ourexperiencewithhydrogelcoatedtrisacrylmicrospheresinuterinearteryembolizationforthetreatmentofsymptomaticuterinefibroidsandadenomyosisafollowupof11years

Ejemplares similares